We noticed that there was no further reduction in tumor size at the higher dose of SKPin C1 (10 mg/kg vs 20 mg/kg), and vinorelbine showed much stronger antitumor effect than SKPin C1 on VHL-deficient RCC tumor xenograft. This evidence concerns the gene VHL and renal cell carcinoma.